Chinese herbal medicine Shenqi compound for early intervention in patients at high cardiovascular risk of type 2 diabetes mellitus: the protocol of a multicenter, randomized, double-blind, placebo-controlled trial

Chinese herbal medicine Shenqi compound for early intervention in patients at high cardiovascular risk of type 2 diabetes mellitus: the protocol of a multicenter, randomized, double-blind, placebo-controlled trial

IntroductionReducing multiple cardiovascular risk factors is a key link and a challenging clinical problem to reduce the risk of cardiovascular complications and death in patients with diabetes. Currently, there is a lack of clinical studies on patients with diabetes combined with multiple risk fact...

Full description

Bibliographic Details
Main Authors:	Yulin Leng, Zehua Zhang, Nairong Yao, Xiaoxu Fu, Hongyan Xie, Hong Gao, Chunguang Xie
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	type 2 diabetes mellitus cardiovascular risk randomized controlled trial traditional Chinese medicine Shenqi compound
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2023.1290240/full

Similar Items

Investigation of the hypoglycemic mechanism of the ShenQi compound formula through metabonomics and 16S rRNA sequencing
by: Juan Gao, et al.
Published: (2024-04-01)

Efficacy and mechanism of Shenqi Compound in inhibiting diabetic vascular calcification
by: Chan Yang, et al.
Published: (2023-12-01)

The efficacy and safety of Chinese herbal medicine as an add-on therapy for type 2 diabetes mellitus patients with carotid atherosclerosis: An updated meta-analysis of 27 randomized controlled trials
by: Zehua Zhang, et al.
Published: (2023-03-01)

The protective role of shenqi compound in type 2 diabetes: A comprehensive investigation of pancreatic β-cell function and mass
by: Chan Yang, et al.
Published: (2023-10-01)

Effects of Jinkui Shenqi and Wuzi Yanzong pill on sperm motility and sperm DNA fragmentation rate in asthenospermia
by: Liangliang Xu, et al.
Published: (2022-12-01)

Efficacy, safety and therapeutic mechanism of Shen-Qi Xiao-Tan formula in the treatment of peripheral atherosclerosis in patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial protocol
by: Yulin Leng, et al.
Published: (2022-12-01)

The efficacy and safety of dachaihu decoction in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis
by: Zehua Zhang, et al.
Published: (2022-08-01)

Systematic review and meta-analysis of shenqi fuzheng and chemotherapy combination in the treatment of breast cancer
by: Ying Li, et al.
Published: (2016-10-01)

The role of Shenqi Fuzheng injection as adjuvant therapy for breast cancer: an overview of systematic reviews and meta-analyses
by: Jing Xu, et al.
Published: (2024-01-01)

Chinese herbal medicine and active ingredients for diabetic cardiomyopathy: molecular mechanisms regulating endoplasmic reticulum stress
by: Lianjun Ao, et al.
Published: (2023-11-01)

Efficacy of Shenqi Jiangtang Granules-Assisted Western Medi-cine in the Treatment of Gestational Diabetes Mellitus (GDM)
by: Juan Tang, et al.
Published: (2021-10-01)

Comparison of efficacy of SHENQI compound and rosiglitazone in the treatment of diabetic vasculopathy analyzing multi-factor mediated disease-causing modules.
by: Hong Gao, et al.
Published: (2018-01-01)

The potential of astragalus polysaccharide for treating diabetes and its action mechanism
by: Shiyu Liu, et al.
Published: (2024-04-01)

The effects of Shenqi Jiangtang granule combined with Western medicine on glucose and lipid metabolism in women with gestational diabetes mellitus
by: Xiaoqiang Hu, et al.
Published: (2022-12-01)

ShenQi FuZheng injection as an adjunctive treatment to chemotherapy in breast cancer patients: a meta-analysis
by: Hongbo Zhang, et al.
Published: (2019-01-01)

Neuroprotective Effects of Shenqi Fuzheng Injection in a Transgenic SOD1-G93A Mouse Model of Amyotrophic Lateral Sclerosis
by: Kazuo Sugimoto, et al.
Published: (2021-10-01)

Neuroprotective effect of Shenqi Fuzheng injection pretreatment in aged rats with cerebral ischemia/reperfusion injury
by: Ying-min Cai, et al.
Published: (2016-01-01)

Comprehensive Quantitative Analysis of SQ Injection Using Multiple Chromatographic Technologies
by: Siu-Leung Chau, et al.
Published: (2016-08-01)

Effectiveness and safety of Shenqi Fuzheng injection combined with platinum-based chemotherapy for treatment of advanced non-small cell lung cancer: a systematic review and meta-analysis
by: Chenxi Qiao, et al.
Published: (2023-08-01)

Authentication of Shenqi Fuzheng Injection via UPLC-Coupled Ion Mobility—Mass Spectrometry and Chemometrics with Kendrick Mass Defect Filter Data Mining
by: Xingdong Wu, et al.
Published: (2022-07-01)

Clinical efficacy of integrated traditional Chinese and western medicine in the treatment of oligoasthenospermia in male infertility of kidney-yang deficiency type
by: Chuchu Gao, et al.
Published: (2023-12-01)

Chinese Herbal Medicine for Type 2 Diabetes Mellitus With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
by: Sihan Peng, et al.
Published: (2022-06-01)

Chinese herbal medicine for chronic heart failure: a multicenter, randomized, double-blind, placebo-controlled trial
by: Liangtao Luo, et al.
Published: (2014-10-01)

Inhibiting apoptosis of Schwann cell under the high-glucose condition: A promising approach to treat diabetic peripheral neuropathy using Chinese herbal medicine
by: Xueru Wang, et al.
Published: (2023-01-01)

The research progress of crosstalk mechanism of autophagy and apoptosis in diabetic vascular endothelial injury
by: Hanyu Liu, et al.
Published: (2024-01-01)

Mechanisms of Kaempferol in the treatment of diabetes: A comprehensive and latest review
by: Yan Yang, et al.
Published: (2022-09-01)

Chinese herbal extract granules combined with 5-aminosalicylic acid for patients with moderately active ulcerative colitis: study protocol for a multicenter randomized double-blind placebo-controlled trial
by: Zhaofeng Shen, et al.
Published: (2021-01-01)

Physiological and pathological characteristics of vascular endothelial injury in diabetes and the regulatory mechanism of autophagy
by: Hanyu Liu, et al.
Published: (2023-06-01)

Efficacy and safety of Qiangli Dingxuan tablet combined with amlodipine besylate for essential hypertension: a randomized, double-blind, placebo-controlled, parallel-group, multicenter trial
by: Jianguo Lin, et al.
Published: (2023-07-01)

Efficacy of Chinese Herbal Medicine Formula in the Treatment of Mild to Moderate Erectile Dysfunction: Study Protocol for a Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
by: Xu RN, et al.
Published: (2023-11-01)

Chinese Herbal Medicine Combined With EGFR-TKI in EGFR Mutation-Positive Advanced Pulmonary Adenocarcinoma (CATLA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
by: Lijing Jiao, et al.
Published: (2019-07-01)

Oral Chinese Herbal Medicine plus usual care for diabetic kidney disease: study protocol for a randomized, double-blind, placebo-controlled pilot trial
by: Meifang Liu, et al.
Published: (2024-02-01)

Efficacy of Xinbao pill on chronic heart failure: Study protocol of a multicenter, randomized, double-blind, placebo-controlled trial
by: Yuanping Wang, et al.
Published: (2022-10-01)

Observation of the effect of bone marrow mesenchymal stem cell transplantation by different interventions on cirrhotic rats
by: Xiaoling Zhou, et al.
Published: (2019-02-01)

Efficacy of Chinese herbal medicine in functional dyspepsia: A meta-analysis of randomized, double-blind, placebo-controlled trials
by: Yu Guo, et al.
Published: (2016-07-01)

Efficacy and safety of a Chinese herbal formula Maxing Ganshi Decoction in children with community-acquired pneumonia: A randomized, double-blind, placebo-controlled, multicenter trial
by: Yujiao Zheng, et al.
Published: (2022-09-01)

Efficacy and safety of naotaifang capsules for hypertensive cerebral small vessel disease: Study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial
by: Rui Fang, et al.
Published: (2023-01-01)

Efficacy and safety of traditional Chinese medicine treatment for idiopathic pulmonary fibrosis: An exploratory, randomized, double-blinded and placebo controlled trial
by: Jiansheng Li, et al.
Published: (2022-10-01)

Placebo design in WHO-registered trials of Chinese herbal medicine need improvements
by: Xuan Zhang, et al.
Published: (2019-11-01)

Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trial
by: Xuedong An, et al.
Published: (2022-04-01)